Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

85.95

-0.33 (-0.38%)

At close: Oct 29, 2026, 4:00 PM EDT

85.80

-0.15 (-0.18%)

After-hours: Oct 29, 2026, 4:52 PM EDT

Corcept Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	830.81	761.41	675.04	482.38	401.86	365.98
Revenue Growth	16.02%	12.79%	39.94%	20.04%	9.80%	3.42%
Cost of Revenue	14.09	12.98	10.88	6.48	5.39	5.28
Gross Profit	816.73	748.43	664.16	475.89	396.47	360.7
Selling, General & Admin	556.47	448.73	280.32	184.26	152.85	122.36
Research & Development	253.86	254.91	246.89	184.35	130.99	113.86
Operating Expenses	810.32	703.63	527.21	368.61	283.84	236.22
Operating Income	6.41	44.8	136.95	107.28	112.63	124.48
Interest & Investment Income	19.96	21.67	24.54	17.28	3.56	0.53
Legal Settlements	-	-	-	-	-14	-
Pretax Income	26.37	66.46	161.49	124.56	116.19	125.01
Income Tax Expense	-28.81	-33.19	20.28	18.42	14.77	12.49
Net Income	55.18	99.65	141.21	106.14	101.42	112.51
Preferred Dividends & Other Adjustments	0.91	1.48	1.48	0.64	0.13	-
Net Income to Common	54.27	98.17	139.73	105.5	101.29	112.51
Net Income Growth	-58.89%	-29.74%	32.45%	4.15%	-9.98%	6.13%
Shares Outstanding (Basic)	104	104	103	104	107	116
Shares Outstanding (Diluted)	118	120	113	112	116	126
Shares Change	-0.22%	5.73%	1.55%	-3.64%	-7.94%	1.42%
EPS (Basic)	0.52	0.95	1.35	1.02	0.95	0.97
EPS (Diluted)	0.45	0.82	1.23	0.94	0.87	0.89
EPS Growth	-59.30%	-33.33%	30.85%	8.05%	-2.25%	4.71%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	106.92	141.79	196.12	126.54	119.91	167.42
Free Cash Flow Per Share	0.91	1.18	1.73	1.13	1.03	1.33
Gross Margin	98.30%	98.30%	98.39%	98.66%	98.66%	98.56%
Operating Margin	0.77%	5.88%	20.29%	22.24%	28.03%	34.01%
Profit Margin	6.53%	12.89%	20.70%	21.87%	25.20%	30.74%
Free Cash Flow Margin	12.87%	18.62%	29.05%	26.23%	29.84%	45.75%
EBITDA	8.08	45.95	137.75	108.32	113.89	125.96
EBITDA Margin	0.97%	6.03%	20.41%	22.46%	28.34%	34.42%
D&A For EBITDA	1.68	1.15	0.8	1.04	1.26	1.48
EBIT	6.41	44.8	136.95	107.28	112.63	124.48
EBIT Margin	0.77%	5.88%	20.29%	22.24%	28.03%	34.01%
Effective Tax Rate	-	-	12.56%	14.79%	12.71%	9.99%

SEC Filings: 10-K · 10-Q